Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Immunofluorescence Assay Detects Virulent Escherichia coli

By Labmedica International staff writers
Posted on 15 Oct 2013
Image: Transmission electron micrograph of Escherichia coli (Photo courtesy of Elizabeth H. White).
Image: Transmission electron micrograph of Escherichia coli (Photo courtesy of Elizabeth H. White).
A sensitive and specific detection method for identifying enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) has been reported.

Among the methods for detection of virulence factor expression, immunoassays for which polyclonal and or monoclonal antibodies are raised, can be considered the first alternative to either animal use or in vitro culture cells assays.

Scientists at Instituto Butantan (Sao Paulo, SP, Brazil) developed a recombinant antibody using the single-chain variable fragment (scFv) approach. They evaluated the sensitivity and specificity of an intimin recombinant antibody (scFv-intimin) using an immunofluorescence assay. A synthetic gene was designed using the scFv-intimin. The intimin adherence-protein gene (eae) encodes for intimin, a 94-kDa outer membrane protein.

The evaluation of scFv-intimin by an indirect immunofluorescence assay test performance implied the use of eae-positive isolates displaying intimin variants, specifically typical EPEC (tEPEC), atypical EPEC (aEPEC), and EHEC, to assess test sensitivity and eae-negative and other Enterobacteriaceae isolates. The prototype tEPEC E2348/69 and enterotoxigenic (ETEC) H10407/E. coli K-12 isolates acted as positive and negative controls, respectively, for assay standardization.

Anti-histidine mouse antibody and goat anti-mouse immunoglobulin G- Fluorescein isothiocyanate (IgG-FITC, Sigma-Aldrich; St. Louis, MO, USA) conjugate were also included as immunofluorescence controls. In all isolates, the eae gene was first assayed by PCR, and the eae positive isolates were confirmed by fluorescent actin staining analysis. A drop of the manipulated bacterial suspension that had also been resuspended with scFv-intimin was placed on a glass slide and observed with a fluorescence microscope (Axioskop-Zeiss; Munich, Germany).

The scFv-intimin immunoassay detected typical EPEC, atypical EPEC, and EHEC isolates with 100% sensitivity and did not detect eae negative isolates, indicating 100% specificity. The authors conclude that immunofluorescence is an effective and rapid method, and scFv-intimin, an excellent tool for the diagnosis of diarrhea caused by EPEC and EHEC and also can be employed in case-control epidemiological surveys. The study was published on October 2, 2013, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Instituto Butantan
Sigma-Aldrich
Axioskop-Zeiss



KARL HECHT GMBH & CO KG
DIASYS DIAGNOSTIC SYSTEMS
Dubai Bio Expo-2015

Channels

Genetic Tests

view channel
Image: The final result of a DNA sequencing process, with each color representing one of the four base chemicals, adenine, guanine, cytosine and thymine, that comprise DNA (Photo courtesy of Gerald Barber).

Gene Sequencing Reference Standard Increases Accuracy for Medical Laboratories

To reduce the variability in genetic test results that has been observed across different clinical laboratories and pathology groups, a new standard DNA reference has been introduced, which will improve... Read more

Hematology

view channel
Image: Immunochemistry of bone marrow biopsy from an acute myeloid leukemia patient showing sheets of CD34 positive cells; corresponding bone marrow aspirate showed only 20% blasts (Photo courtesy of All India Institute of Medical Sciences).

Immunohistochemistry Assesses Early Response in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to prognosis and early response assessment has an established role as predictor of remission rate, and overall and disease-free survival.... Read more

Industry News

view channel

Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer

An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer. The liquid biopsy test is based on bladder cancer DNA methylation biomarkers developed... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.